Vimarsana
Biggest News Aggregation in the World

Jason Eric Evans News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jason Eric Evans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jason Eric Evans Today - Breaking & Trending Today

Surgery Partners (NASDAQ:SGRY) Shares Up 2% - Vimarsana News

Surgery Partners (NASDAQ:SGRY) Shares Up 2%

Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) shot up 2% during mid-day trading on Wednesday . The company traded as high as $26.05 and last traded at $26.05. 34,319 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 917,925 shares. The stock had previously closed at $25.53. […]

Benchmark Reaffirms "Buy" Rating for Surgery Partners (NASDAQ:SGRY) - Vimarsana News

Benchmark Reaffirms "Buy" Rating for Surgery Partners (NASDAQ:SGRY)

Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Benchmark in a research note issued to investors on Wednesday, Benzinga reports. They presently have a $50.00 target price on the stock. Benchmark’s price target would suggest a potential upside of 103.83% from the company’s current price. […]

Benchmark Reiterates "Buy" Rating for Surgery Partners (NASDAQ:SGRY) - Vimarsana News

Benchmark Reiterates "Buy" Rating for Surgery Partners (NASDAQ:SGRY)

Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Benchmark in a research note issued on Wednesday, Benzinga reports. They currently have a $50.00 price objective on the stock. Benchmark’s price target indicates a potential upside of 103.83% from the company’s current price. A number of other […]

Surgery Partners' (SGRY) Buy Rating Reaffirmed at Benchmark - Vimarsana News

Surgery Partners' (SGRY) Buy Rating Reaffirmed at Benchmark

Benchmark reissued their buy rating on shares of Surgery Partners (NASDAQ:SGRY – Free Report) in a research note published on Wednesday morning, Benzinga reports. They currently have a $50.00 target price on the stock. Other equities research analysts also recently issued research reports about the company. Citigroup decreased their price target on Surgery Partners from […]

Source: wkrb13.com
StockNews.com Upgrades Surgery Partners (NASDAQ:SGRY) to Hold - Vimarsana News

StockNews.com Upgrades Surgery Partners (NASDAQ:SGRY) to Hold

Surgery Partners (NASDAQ:SGRY – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Thursday. Several other research firms have also weighed in on SGRY. Cantor Fitzgerald restated an “overweight” rating and set a $43.00 price target on shares of Surgery […]